AstraZeneca’s Farxiga prolongs survival in chronic kidney disease trial
AstraZeneca has reported positive data from a subgroup analysis from Phase III DAPA-CKD trial of...
Interim results of the SOLIDARITY trial failed to show efficacy of repurposed drugs in mortality of hospitalized Covid-19 patients
The World Health Organization’s Phase II/III SOLIDARITY trial for COVID-19 is currently the world’s largest...
Goldfinch Bio reports positive data from GFB-887 trial
Goldfinch Bio has reported positive results from its Phase I clinical trial of GFB-887, a...
Moderna completes enrolment for mRNA-1273 trial against Covid-19
Moderna has completed the enrolment of participants for the Phase III COVE study of its...
Positive data for Amylyx’s AMX0035 strengthen its position to enter ALS market
On October 16, Amylyx announced that AMX0035, its amyotrophic lateral sclerosis (ALS) pipeline drug, showed...
GSK reports positive data from trials of RSV vaccine candidates
GlaxoSmithKline (GSK) has reported positive results from Phase I/II clinical trials of Respiratory Syncytial Virus...
WHO’s Solidarity trial shows repurposed drugs for Covid-19 are ineffective
World Health Organization (WHO) has reported that interim data from the Solidarity Therapeutics Trial of...
Sanofi and Translate Bio find positive preclinical Covid-19 vaccine results
Sanofi’s vaccines global business unit Sanofi Pasteur and Translate Bio have reported preclinical trial results...
SynapCon
SynapCon specialises in the development of innovative software solutions for clinical trial and medical research...